Operating Lease, Right-of-Use Asset of TriSalus Life Sciences, Inc. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
TriSalus Life Sciences, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • TriSalus Life Sciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $861,000, a 29% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

TriSalus Life Sciences, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $861,000 -$349,000 -29% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 $890,000 -$537,000 -38% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $1,103,000 -$20,000 -1.8% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $1,137,000 -$59,000 -4.9% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $1,210,000 +$31,000 +2.6% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 $1,427,000 +$175,000 +14% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $1,123,000 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $1,196,000 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $1,179,000 -$202,000 -15% 31 Dec 2023 10-K/A 30 May 2025 2024 FY
Q3 2023 $1,252,000 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q4 2022 $1,381,000 31 Dec 2022 10-K 11 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.